Abstract
(Aust N Z J Obstet Gynaecol. 2020;60:890–895) Placenta previa affects 1 in 200 deliveries at term, and 90% resolve by the third trimester. One of the major adverse maternal outcomes associated with placenta previa is antepartum hemorrhage (APH), which can lead to blood transfusions, hysterectomy or admission to the intensive care unit (ICU), among other adverse events. Little has been published about the management of outcomes associated with placenta previa. The aim of this study was to examine the associations between APH, postpartum hemorrhage (PPH) and adverse outcomes in women with placenta previa.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
